93 related articles for article (PubMed ID: 9058512)
1. Cytofluorometric and cytogenetic evaluation of renal cell carcinoma: correlations with the clinical course.
Bartoletti R; Selli C; Nicolò G; Margallo E; Amorosi A
Urol Int; 1997; 58(1):1-7. PubMed ID: 9058512
[TBL] [Abstract][Full Text] [Related]
2. Cytofluorometric evaluation of nuclear DNA content distribution in renal neoplasms treated by conservative surgery.
Selli C; Nicolò G; Margallo E; Bartoletti R; Amorosi A
Urol Int; 1996; 57(3):151-7. PubMed ID: 8912443
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
Ljungberg B; Larsson P; Stenling R; Roos G
J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of DNA ploidy in small renal cell carcinoma.
Shalev M; Gdor Y; Leventis A; Radnay J; Shapiro H; Bernheim J; Nissenkorn I
Pathol Res Pract; 2001; 197(1):7-12. PubMed ID: 11209819
[TBL] [Abstract][Full Text] [Related]
6. Localized renal cell carcinoma treated by radical nephrectomy. Influence of pathologic data and the importance of DNA ploidy pattern on disease outcome.
Raviv G; Leibovich I; Mor Y; Nass D; Medalia O; Goldwasser B; Nativ O
Cancer; 1993 Oct; 72(7):2207-12. PubMed ID: 8374878
[TBL] [Abstract][Full Text] [Related]
7. Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma.
Di Silverio F; Casale P; Colella D; Andrea L; Seccareccia F; Sciarra A
Cancer; 2000 Feb; 88(4):835-43. PubMed ID: 10679653
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and corresponding flow cytometric DNA analysis of renal cell neoplasms.
el-Naggar AK; Pathak S
Anticancer Res; 1992; 12(5):1491-500. PubMed ID: 1444211
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA
Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079
[TBL] [Abstract][Full Text] [Related]
11. [Bellini renal cell carcinoma : diagnosis and treatment. A report of 7 cases].
Sallami S; Tanguour M; Ben Rhouma S; Cherif K; Kchir N; Horchani A
Tunis Med; 2011 Oct; 89(10):792-6. PubMed ID: 22076905
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic studies in renal cell carcinoma patients receiving low-dose recombinant interleukin-2-based immunotherapy.
Duensing S; van den Berg-de Ruiter E; Störkel S; Kirchner H; Hänninen EL; Buer J; Poliwoda H; Atzpodien J
Tumour Biol; 1996; 17(1):27-33. PubMed ID: 7501970
[TBL] [Abstract][Full Text] [Related]
13. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
Eskelinen M; Lipponen P; Nordling S
Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy status and DNA content instability within single tumors in renal cell carcinoma.
Bringuier PP; Bouvier R; Berger N; Piaton E; Revillard JP; Perrin P; Devonec M
Cytometry; 1993; 14(5):559-64. PubMed ID: 8354129
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
[TBL] [Abstract][Full Text] [Related]
17. Flow-cytometric DNA analysis of paraffin-embedded renal cell carcinoma tissue from patients treated by parenchymal-sparing surgery.
Ciancio G; Ferrell S; Block NL
Br J Urol; 1995 Nov; 76(5):570-4. PubMed ID: 8535674
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of cytogenetic analysis in clear cell renal carcinoma: a study on 131 patients with long-term follow-up.
Antonelli A; Arrighi N; Tardanico R; Balzarini P; Zanotelli T; Corti S; Zani D; Cozzoli A; Cunico SC; Simeone C
Anticancer Res; 2010 Nov; 30(11):4705-9. PubMed ID: 21115928
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic, flow cytometric, and ultrastructural studies of twenty-nine nonfamilial human renal carcinomas.
Wolman SR; Camuto PM; Golimbu M; Schinella R
Cancer Res; 1988 May; 48(10):2890-7. PubMed ID: 3359446
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
